Latest Shareholder Approvals News

Zimi Limited has paused its planned capital raising amid ongoing talks, while revealing strong operational momentum including $1.42 million in open orders and expanded market partnerships.

Dropsuite secures Foreign Investment Review Board approval for its acquisition by NinjaOne, clearing a major regulatory hurdle ahead of the upcoming shareholder vote. Meanwhile, ASIC grants an extension for Dropsuite’s 2025 AGM, reflecting the pending transaction timeline.

Enlitic has signed a binding MoU with GE HealthCare to deliver up to A$50 million in migration services over five years, contingent on a A$10 million equity raise that the company has now initiated.

Infinity Mining has executed a binding agreement to divest its Leonora Goldfields Project interest to U Resource, which will transfer it to Evergreen Lithium (ASX: EG1). Infinity retains exposure through a substantial EG1 shareholding while refocusing on its core assets.

Proteomics International Laboratories Ltd is raising up to $5.5 million through a $4 million placement and a $1 million Share Purchase Plan at $0.37 per share, offering shareholders a discounted entry and free attaching options.

FXG has announced a $17 million two-tranche placement priced at A$0.155 per share, aimed at advancing drilling and exploration activities in Alaska. The second tranche awaits shareholder approval, marking a pivotal funding milestone for the company.

Felix Gold Limited has successfully raised $17 million through a two-tranche placement, bolstering its cash reserves to advance exploration and development in Alaska’s prolific Fairbanks Gold District.

Anax Metals has locked in a $3.3 million convertible note investment from Mineral Development Partners, with conditional commitments for up to $100 million to advance the Whim Creek Project and establish a Pilbara base metals hub.

Conrad Asia Energy has successfully raised approximately A$9 million through a two-tranche placement, with strong insider participation, to fund key milestones in its flagship Mako gas development and other projects.

Excite Technology Services has raised $2.8 million through a placement to accelerate growth in cybersecurity services and training, including investment in its flagship Nangu Tactical Centre.

Bio-Gene Technology Limited has raised $2.1 million through a placement and launched a Share Purchase Plan to fund critical safety studies for its flagship insecticide Flavocide®, alongside development of Qcide and strategic initiatives.

Enlitic, Inc. has launched a two-tranche institutional placement to raise A$10 million, underpinning its strategic collaboration with GE HealthCare and fueling expansion in AI-enabled medical imaging data migration.